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Abstract: Aging and injury are two major risk factors for osteoarthritis (OA). Yet, very little is
known about how aging and injury interact and contribute to OA pathogenesis. In the present
study, we examined age- and injury-related molecular changes in mouse knee joints that could
contribute to OA. Using RNA-seq, first we profiled the knee joint transcriptome of 10-week-old,
62-week-old, and 95-week-old mice and found that the expression of several inflammatory-response
related genes increased as a result of aging, whereas the expression of several genes involved in
cartilage metabolism decreased with age. To determine how aging impacts post-traumatic arthritis
(PTOA) development, the right knee joints of 10-week-old and 62-week-old mice were injured
using a non-invasive tibial compression injury model and injury-induced structural and molecular
changes were assessed. At six-week post-injury, 62-week-old mice displayed significantly more
cartilage degeneration and osteophyte formation compared with young mice. Although both age
groups elicited similar transcriptional responses to injury, 62-week-old mice had higher activation
of inflammatory cytokines than 10-week-old mice, whereas cartilage/bone metabolism genes had
higher expression in 10-week-old mice, suggesting that the differential expression of these genes
might contribute to the differences in PTOA severity observed between these age groups.
Keywords: osteoarthritis; aging; PTOA; gene expression; RNA-seq; cartilage degeneration;
scRNA-seq; chondrocytes
1. Introduction
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage loss,
bone remodeling, synovial inflammation, and significant joint pain, often resulting in disability [1].
According to Center for Disease Control statistics, approximately 30 million people in the United
States are estimated to have OA. Currently, there are no approved therapies available to prevent
degeneration or rebuild articular cartilage destroyed by OA. Existing treatments mainly target the
symptoms, and advanced OA often requires joint replacement [1]. A more in-depth understanding of
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the pathophysiology of the disease will likely lead to the development of novel therapeutic strategies
for the prevention and/or treatment of OA.
Aging is a key risk factor for the development of OA. It is estimated that, by 2050, people over
the age of 60 will account for more than 20% of the world’s population. Of that, ~15–20% will have
symptomatic OA, and one-third of these people will be severely disabled. In addition to age, joint
injury is also a common risk factor for OA. OA that develops because of a joint injury is defined as
post-traumatic OA (PTOA). Clinical statistics reveal that ~50% of people with injury to the anterior
cruciate ligament (ACL) or the meniscus will develop PTOA within 1–2 decades of the injury [2]. It has
also been suggested that age and joint injury interact and have a combined effect on the development
and progression of OA following joint trauma. The average time from meniscal injury to the onset of
radiographic signs of OA in patients older than 30 was five years; in sharp contrast, patients between
17 and 30 years of age were asymptomatic for up to 15 years [3]. Although several studies have
investigated the role of age and injury in the development of OA, the mechanisms by which age and
injury interact to contribute to OA pathogenesis are still not well understood [4–7].
Recently, using a noninvasive tibial compression (TC) injury model of PTOA, we investigated
molecular and structural changes in the knee joints of young (10-16 weeks-old) mice following ACL
injury [8–10]. These mice showed significant cartilage erosion, subchondral bone loss, and osteophyte
formation as early as 4–6 weeks post-injury [8–10]. Gene expression analysis using RNA-seq revealed
that a significant number of genes associated with inflammatory responses were elevated shortly after
the injury (one-day post-injury) and several genes associated with cartilage and bone remodeling were
elevated at 1–6 weeks post-injury [8,10].
In the present study, we compared OA-associated changes in the knee joints of mice ranging in age
from 10 to 95 weeks old, to determine the contribution of age to OA pathogenesis. First, we identified
age-related molecular changes in healthy (uninjured) knee joints by comparing gene expression in
10-week-old, 62-week-old, and 95-week-old mice. Then, using the TC injury model [11], we compared
molecular and structural changes associated with PTOA development between 10- and 62-week-old
mice, to better understand how age and joint injury interact to contribute to the development of PTOA.
We found that the old mice displayed a more severe cartilage degeneration phenotype and increased
osteophyte formation in response to injury compared with the younger mice. We also identified
significant differences in injury-induced response genes between old and young mice, including an
increased expression of inflammatory-response related genes and reduced expression of genes involved
in cartilage and bone development in old mice, which could have contributed to the more severe PTOA
phenotype observed in old mice.
2. Results
2.1. Aging Up-Regulated Inflammatory Response-Related Genes and Down-Regulated Genes Associated with
Cartilage Development and Homeostasis in Mouse Knee Joints
To determine aging-related molecular changes in healthy (uninjured) knee joints, we profiled
the knee joint transcriptome of 10-week-old, 62-week-old, and 95-week-old mice using RNA-seq.
Compared with 10-week-old mice, 974 and 1732 genes were up-regulated and 1006 and 1386 genes
were down-regulated in 62-week-old mice and 95-week-old mice, respectively (Figure 1A,B, Table S1).
Six-hundred and four genes including 42 arthritis-associated genes (Mmp3, Ccl3, Ccr5, Csf3, Cxcr6,
Lyz1, Il33, and Tnfsf15, among others), 110 genes associated with immune response (Tlr7, Csf3, Cd3d,
Cd4, Nlrp1b, and Cd8a, among others) and 47 inflammatory response-related genes (Ccl5, Ccr5, Cxcl1,
and Cxcl5, among others) were up-regulated in both 62-week-old and 95-week-old old mice compared
with 10-week-old mice (Figure S1A, Figure 1C). Of these common up-regulated genes, 143 genes
including several key regulators of immune/inflammatory responses such as Il5ra, Il17re, Cxcr3, Cxcr6,
Cxcl5, Cxcl9, Ccl3, and Ccl4 had a significantly higher expression in 95-week-old mice compared with
62-week-old mice, suggesting a progressive increase in the levels of inflammatory mediators in the joint
with age (Figure 1C,E). Genes down-regulated in both 62-week-old and 95-week-old mice compared
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with 10-week-old mice included 39 genes associated with cartilage development (Col2a1, Col9a1, Sox9,
Acan, and Comp, among others), 40 genes associated with bone development (Col1a1, Alpl, Sparc, Bglap,
and Runx2, among others), 35 genes involved in osteoblast differentiation, and 22 genes involved in
chondrocyte differentiation (Figure 1D, Figure S1B–D). Several key regulators of cartilage development
and homeostasis including Sox9, Col2a1, and Acan had the lowest expression in 95-week-old mice,
indicating a reduction in cartilage anabolic responses with age (Figure 1F).
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2.2. Injury-Induced Knee Joint Degeneration was Accelerated in Old Mice
To understand how aging impacts PTOA development after injury, we investigated structural
changes in the knee joints of 62-week-old and 10-week-old mice six weeks after an ACL injury.
Ten-week-old mice represent young adult humans whose cartilage is normally healthy, whereas
62-week-old mice represent a ~50–60 year-old human, an age group in which OA is prevalent.
By six-week post-injury, both 10-week-old and 62-week-old mice exhibited severe cartilage degradation
in the injured joints (Figure 2A,B). OA lesions were more severe in 62-week-old mice than in 10-week-old
mice, where the majority of the femoral head was lacking the articular cartilage layer in the injured
62-week old mice (Figure 2A). Osteophyte formation was observed in both age groups by six-week
post-injury, and 62-week-old mice had significantly more osteophytes than 10-week-old mice (Figure 2C).
ACL injury also resulted in a significant reduction in subchondral bone volume in the femoral epiphysis
in both age groups (Figure 2D). Older, 62-week-old mice displayed a significantly lower subchondral
bone volume than 10-week-old mice before injury, and they also lost more subchondral bone (25% loss)
than younger mice (18% loss) by six weeks after injury (Figure 2D).
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10-week-old an 62-week-old mice. (A) Histological e l ti n of uninjured contralateral joints and
injured joints at six-week post-injury using Safranin-O and Fast Green staining which stains cartilage in
red and surrounding tissue in green (5×magnification). Scale bars: 200 µm. (B) Osteoarthritis Research
Society International (OARSI) scoring of histological sections of injured and uninjured contralateral
joints at six-week post-injury. (C) Osteophyte volume at six-week post-injury. (D) Epiphyseal trabecular
bone volume fraction (BV/TV) of the distal femur was quantified using µCT and analyzed between
injured and uninjured contralateral joints at six-week post-injury. 10W: 10-week-old; 62W: 62-week-old.
* p < 0.05, ** p < 0.01, *** p < 0.001.
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2.3. Age-Related Differences in ACL Injury-Induced Gene Expression Changes in the Knee Joints
To determine how aging impacts PTOA development at the molecular level, we compared
injury-induced gene expression changes in both 10-week-old and 62-week-old mice at six-week post-injury.
RNA-seq analysis identified 699 and 255 genes differentially expressed in injured knee joints of 10-week-old
mice and 62-week-old mice, respectively, compared with respective uninjured contralateral joints
(Figure 3A, Table S2). Of these genes, 184 up-regulated genes were common to both age groups (Figure 3B).
These genes included 41 genes involved in extracellular matrix organization (Htra1, Fn1, Comp, Tnc, Dcn,
Bgn, Sulf1, Loxl1, Loxl2, Has1, Lum, Plod2, and Collagens, among others), 19 genes involved in collagen
metabolic process (Collagens, Mmp2, and Mmp3, among others), 14 genes involved in cartilage development
(Col2a1, Col10a1, Comp, Ror2, Osr2, Pth1r, Thbs3, Sulf1, and Loxl2, among others), and 24 genes involved in
bone development and metabolism (Cthrc1, Ibsp, Sparc, Pth1r, and Enpp1, among others). Of these common
up-regulated genes, 113 genes including several regulators of cartilage and bone development/metabolism
such as Chad, Col10a1, Col2a1, Comp, Pth1r, Ror2, Ibsp, and Sparc had higher expression in injured joints of
10-week-old mice compared with injured joints of 62-week-old mice, suggesting a more active cartilage
and bone remodeling in young mice after injury (Figure 3B,C, Table S2).
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Figure 3. Age related differences in anterior cruciate ligament (ACL) injury-induced gene expression
changes at six-week post-injury. (A) Number of genes differentially expressed in response to injury in
10-week-old and 62-week-old mice at six-week post-injury. (B) Overlap between genes up-regulated in
10-week-old and 62-week-old mice compared with respective uninjured controls and genes up-regulated
in injured joints of 10-week-old compared with injured joints of 62-week-old mice. (C) Injury-induced
regulators of cartilage and bone development/metabolism showing highest expression in injured joints
of 10-week-old-mice. 10W_I: injured joints of 10-week-old; 10W_U: uninjured joints of 10-week-old;
62W_I: injured joints of 62-week-old; 62W_U: uninjured joints of 62-week-old.
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We also identified 356 genes up-regulated only in 10-week-old injured joints, which included
several regulators of skeletal system development (Phex, Sulf2, Fbn1, Fbn2, Sfrp1, Tnfrsf11b, Hapln1, Igf1,
and Rspo2, among others), extracellular matrix organization (Dmp1, Mmp12, Mmp19, Adamts2, Tnc, and
Loxl1, among others), inflammatory response (Cxcl10, C3ar1, C4b, Ccr5, Ccl8, and Il33, among others),
and Wnt signaling (Fzd1, Nfatc4, Wnt16, Sfrp1, Sfrp4, Nkd2, Prickle2, Rspo2, Rspo1, and Dkk3, among
others) (Figure 3B, Table S2). Sixty-nine genes were specifically up-regulated in 62-week-old mice
compared with respective uninjured controls, which included several regulators of bone development
and metabolism (Postn, Bmp1, Sfrp2, Gja1, Ptn, Alpl, Sp7, and Mmp14, among others) (Figure 3B,
Table S2). However, 23 of these 69 genes including Alpl, Sp7, Bmp1, and Mmp14 had higher expression
in both injured and uninjured joints of 10-week-old mice compared with 62-week-old mice (Table S2).
Two genes (Kcna3 and Gm30934) were down-regulated in 62-week-old mice, whereas 159 genes were
down-regulated in 10-weekold mice in response to injury, and none of these genes overlapped with
genes down-regulated in 62-week-old mice (Table S2).
We have previously shown that, in young mice, inflammatory response genes were highly
up-regulated immediately post-injury and a large number of genes associated with cartilage and
bone remodeling were highly elevated at one-week and two weeks post-injury [8,10]. To identify the
differences in injury-induced early molecular changes between the young and old, we profiled the knee
joint transcriptome of 62-week-old mice at one-day, one-week, and two weeks post-injury. Our analysis
identified 779, 1486, and 1299 genes differentially expressed in injured knee joints of old mice at one-day,
one-week, and two-weeks post injury, respectively, compared with respective uninjured contralateral
joints (Figure 4A, Table S2). In 10-week-old mice, 755, 811, and 596 genes were differentially expressed at
one-day, one-week, and two weeks post injury, respectively (Figure 4B, Table S2). We also observed a
huge overlap between genes up-regulated in both age groups at early post-injury timepoints (Table 1).
This included 48 genes up-regulated in both age groups at all post-injury timepoints examined in this
study (Table 2).
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Figure 4. Injury-induced transcriptional changes at early post-injury timepoints. Number of genes up-
and down-regulated in injured knee joints of 62-week-old (A) and 10-week-old (B) mice at one-day (1D),
one-week (1W), and two weeks (2W) post-injury compared with uninjured contralateral joints. (C) Key
biological processes associated with genes up-regulat d in 62-w ek- ld mice and 10-week-old mice
at early timepoints. (D) Inflammatory cytokines up-regulated at one-day post-injury in 62-week-old
mice. (E) Matrix degrading enzymes up-regulated in 62-week-old mice after injury. Majority of these
had highest expression at 1–2 weeks post-injury. 10W: 10-week-old; 62W: 62-week-old; 1DPI: one-day
post-injury; 1WPI: one-week post-injury; 2WPI: two weeks post-injury.
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Table 1. Table showing up-regulated genes shared between 10-week-old and 62-week-old mice at
various post-injury timepoints.
Time Post-Injury 62-Week-Old
1 Day (Total: 537) 1 Week (Total: 1343) 2 Weeks (Total: 1235) 6 Weeks (Total: 253)
10-week-old
1 Day (Total: 479) 246 288 256 78
1 Week (Total: 627) 227 536 534 179
2 Weeks (Total: 535) 196 465 462 177
6 Weeks (Total: 540) 170 427 430 184
Injury-induced genes in both young and old mice showed enrichment for similar biological
processes at early post-injury timepoints (Figure 4C). Similar to what we have previously shown
for young mice [10], 62-week-old mice also displayed an up-regulation of inflammatory response
related genes at one-day post-injury (Figure 4C,D, Table S2). These genes included several cytokines
that also showed an increase in expression with age such as Ccl8, Cxcl5, and Il33 (Table S1). As in
the case of young mice [10], a large number of genes involved in extracellular matrix organization
and cartilage/bone metabolism including core matrix proteins such as collagens, Fn1, Dcn, Eln, Fbn1,
Fbn2, Bgn, Acan, Cthrc1, Postn, Prelp, Prg4, and Vcan and matrix degrading enzymes such as Mmp2,
Mmp3, Adamts2, and Adamts3 showed an increased expression in the injured joints of 62-week-old
mice compared with uninjured controls (Figure 4E, Figure S2, Table S2). The majority of these genes
had the highest expression at 1–2 weeks post-injury, indicating a more active tissue remodeling at this
timepoint (Figure 4E, Figure S2). We also observed that a number of collagen processing enzymes
such as Lox, Loxl2, Loxl3, and Plod2 were activated by injury in both age groups (Figure S3A). Using
single-cell RNAseq (scRNA-seq) data from adult mouse knee joint cartilage, we also determined
that mature chondrocytes robustly express Loxl2, Loxl3, and Plod2, whereas Lox expression was more
restricted to immature chondrocytes/mesenchymal progenitors (Figure S3B).
Table 2. Genes up-regulated in injured joints of both young and old mice at all timepoints examined.
Fold change (log2 scale) values are shown in the table (false discovery rate (FDR) < 0.05 for all genes).
Age Young Old
Gene 1 Day 1 Week 2 Weeks 6 Weeks 1 Day 1 Week 2 Weeks 6 Weeks
Adamts12 0.649 1.324 0.917 0.783 1.225 2.363 1.898 0.804
AW551984 1.397 1.863 1.662 1.048 1.479 2.865 2.787 1.106
Bmper 1.402 1.245 1.039 1.023 1.436 1.447 1.443 0.813
Col14a1 1.112 2.110 1.552 1.424 0.730 2.939 2.508 1.016
Col18a1 0.741 1.263 1.124 0.606 1.003 2.268 1.758 0.689
Col3a1 1.543 2.075 1.683 1.594 2.395 4.267 3.878 2.270
Col5a1 0.916 1.441 0.995 0.781 1.053 3.080 2.482 1.078
Col5a2 0.725 1.157 0.793 1.036 1.304 3.118 2.815 1.381
Col5a3 0.670 1.119 0.735 1.080 0.690 2.137 1.783 1.007
Col6a1 0.752 1.674 1.282 0.992 0.934 3.155 2.603 1.256
Col6a2 0.752 1.688 1.287 1.162 0.993 3.170 2.639 1.156
Col6a3 0.930 1.807 1.156 1.292 1.436 3.188 2.564 1.270
Col8a1 0.609 0.748 0.615 0.590 0.965 1.681 1.537 0.701
Crabp2 1.600 2.440 2.452 1.956 1.842 3.802 4.167 1.867
Cthrc1 1.686 2.050 1.281 1.488 1.765 4.493 3.955 1.914
Dab2 0.994 1.056 0.888 0.606 1.200 1.697 1.668 0.772
Dsel 0.692 1.267 0.736 0.919 0.686 1.764 1.700 1.005
Enpp1 0.685 1.408 0.789 1.393 0.860 1.914 2.009 1.265
Fcrls 1.990 1.288 1.208 0.895 2.233 2.501 2.223 1.005
Fndc1 0.825 1.977 1.474 1.413 0.668 2.795 2.227 1.023
Fstl1 1.196 1.500 1.217 0.895 1.278 2.371 2.128 0.745
Int. J. Mol. Sci. 2020, 21, 364 8 of 17
Table 2. Cont.
Age Young Old
Gene 1 Day 1 Week 2 Weeks 6 Weeks 1 Day 1 Week 2 Weeks 6 Weeks
Has1 1.367 1.921 1-.955 3.181 3.310 2.894 2.648 1.590
Hhipl1 1.551 1.644 1.067 1.431 1.357 1.896 1.780 1.386
Igsf10 0.990 1.772 1.072 1.405 0.750 2.965 2.662 1.479
Kcnj15 1.108 2.295 1.724 2.637 1.566 2.779 2.562 1.192
Lrrc17 2.079 1.925 1.112 0.871 1.316 2.565 2.359 0.912
Mfap5 1.189 1.732 1.322 1.094 1.214 2.235 2.038 0.893
Mmp3 1.648 1.988 2.032 1.094 3.513 2.440 3.143 2.060
Mrgprf 1.071 1.967 1.493 1.309 0.848 2.582 2.138 0.988
Nox4 1.343 1.028 1.303 1.185 1.240 1.604 1.489 1.066
P4ha3 2.305 2.528 1.917 1.187 2.206 4.191 3.840 1.621
Plce1 0.648 0.863 0.672 0.668 0.657 1.160 1.099 0.704
Prg4 0.733 1.228 1.273 1.817 1.618 1.526 1.471 1.620
Prrx2 1.492 1.385 1.176 0.838 1.773 3.217 2.546 1.032
Ptgfrn 0.726 1.164 0.802 0.754 1.131 2.010 1.697 0.775
Slc16a2 1.413 1.655 0.950 0.792 1.360 1.783 1.654 0.782
Slc1a4 0.984 1.629 1.206 1.143 1.566 2.347 1.991 1.319
Slc41a2 0.727 0.814 0.619 0.621 1.026 1.096 1.438 0.711
Srpx2 0.842 1.219 0.867 1.054 1.207 2.155 2.032 0.839
Sulf1 0.896 1.245 0.911 1.029 1.333 1.743 1.713 0.903
Thbs2 0.958 1.614 0.831 0.733 0.684 2.893 2.294 1.086
Thbs3 0.643 1.773 1.330 1.429 1.115 3.018 2.660 1.214
Thbs4 0.832 0.925 0.974 0.695 1.349 1.717 1.546 1.052
Timp1 2.037 1.193 1.059 1.132 4.129 2.886 2.697 1.377
Tmem45a 0.606 1.129 0.788 0.940 1.361 2.375 2.159 0.990
Tnfaip6 1.941 1.804 1.345 2.636 3.897 3.911 3.240 1.722
Tnn 1.117 1.722 1.019 1.056 1.098 4.072 3.469 1.830
Although injury activated a large number of genes involved in cartilage anabolism in both
age groups, histological analysis (Figure 2) suggested that this was not sufficient to prevent joint
degeneration. To further investigate this, we performed immunohistochemistry analysis of two
injury-induced genes: chondroadherin (Chad), a leucine rich repeat extracellular matrix protein
that is synthesized by chondrocytes and reported to promote their attachment [12]; and Plod2,
an enzyme involved in collagen synthesis [13]. Consistent with gene expression data (Table S1),
immunohistochemistry showed lower Chad and Plod2 protein expression in the articular cartilage
of old mice compared with young mice, confirming a decrease in expression with age (Figure 5C,D).
However, in contrast to an increase in the transcript levels observed after injury (Table S2), injured
joints of both age groups had significantly lower Chad and Plod2 protein expression compared with
respective uninjured controls, suggesting that the increase in gene expression in response to injury
failed to translate into increased protein expression. Alternatively, other cells in the joint may have
up-regulated the transcript levels of these genes, in which case the non-cartilage derived RNA would
account for higher transcript levels in the injured joints.
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1 (Cytl1) [14,15], a gene potentially i volved in chondr genesis and cartilage development, was
down-regulated in 10-week-o d mice at all post-injury timepoint a d in 62-weeks old mice at on -day,
one-w ek, and two weeks post-injury (Figure 6A), a d this trend was consistent when protein levels
w re analyzed by immunohistochemistry (Figure 6B), suggesting that Cytl1 corr lates with PTOA
severity. scRNA-seq analysis of adult mouse knee joint cartilage showed th t Cytl1 was robustly
expressed by a specific chondrocyte subpopulation, which also expressed high levels of Bmp2, Wif1,
and Prg4, genes that play a role i chondrocyte diff rentiation and maintenance [16–18] (Figur 6C–E),
indicatin a spatially restric ed expression pat ern for this gene in th cartilage and a po enti l role in
the development and maintenance of he articular c rtilage.
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3. Discussion
Aging and injury are two key risk factors for OA. Several studies have investigated how aging
and injury independently contribute to OA pathogenesis; however, very limited data are available
on how aging and injury interact to influence OA progression [4]. In this study, we investigated the
differences in molecular responses of young and old mice to knee joint injury using RNA-seq. Our
study identified several age-related structural and molecular changes in mouse knee joint during
PTOA development and progression.
Histological analysis showed that both 10-week-old and 62-week-old mice exhibited significant
joint degeneration by six-week post-injury. Consistent with previous reports [4], older mice had more
severe articular cartilage degeneration compared with young mice. Both age groups had deficits
in epiphyseal trabecular bone in the injured joint and exhibited considerable osteophyte formation,
which was more severe in older animals. Old mice also showed lower trabecular bone volume fraction
(BV/TV) compared with the young mice, suggesting an age-dependent bone loss. Our previous study
showed peak trabecular bone changes at approximately two weeks post injury, while mineralized
osteophytes were not observable by µCT until about four weeks [19]. In this study, we only examined
six-week post-injury joints using µCT and histology, and the joints were severely damaged in both age
groups by six-week post-injury. Examining an earlier time point (e.g., 2–4 weeks post-injury) would
potentially allow us to more clearly see differences in PTOA progression between old and young mice
and determine whether aging accelerates PTOA.
At a molecular level, older mice had significantly higher expression of inflammatory signaling
genes including Ccl3, Ccl4, Ccl5, Ccl8, Cxcl5, Cxcl9, Cxcl13, Il6, and Il33 compared with young mice and
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the expression of many of these inflammatory cytokines increased with age, with 95-week-old mice
showing the highest expression (Figure 1C). A study comparing gene expression in joint tissues from
12-week-old mice and 12-month-old mice has shown that the expressions of Il6, Il33, Cxcl9, Cxcl13,
Ccl8, and Ccl5, were significantly up-regulated in the old mice compared with the young [4], which is
consistent with our observation. We also found that knee joint injury further activated the expression
of many of these genes in both young and old mice at one-day post-injury, and the majority of these
genes reverted to the uninjured control level by 1–2 weeks post-injury in both age groups. It has
been suggested that inflammation plays a key role in the pathogenesis of osteoarthritis; inflammatory
mediators may promote cartilage degradation either directly or indirectly through the induction
of proteolytic enzymes [20,21]. Low innate production of interleukin (IL)-6 has been shown to be
associated with the absence of osteoarthritis in old age [22]. It has also been shown that STR/ort, a
mouse strain with high susceptibility to OA, expresses high levels of inflammatory markers, whereas
MRL/MpJ, a mouse strain resistant to PTOA, had low expression values for these genes [10,23,24].
These data together suggest that an increase in the levels of inflammatory mediators with age might
have played a role in the enhanced joint degeneration observed in older mice.
Consistent with previous studies demonstrating an age-related decline in chondrocyte anabolic
responses [4,25], we observed a significant reduction in the expression of genes involved in cartilage
development and metabolism including Sox9 [26], Col2a1, Col9a1-a3 [27], Acan, Comp, Perlecan
(Hspg2) [28], and Hapln1 [29] with age (Table S1). Bmp7, a key regulator cartilage homeostasis and
cartilage repair [30], also showed reduced expression in old animals. Chondroadherin (Chad), a
cartilage matrix protein thought to mediate chondrocyte adhesion, also displayed a down-regulation
with age [12]. However, knee joint injury activated the expression of many of these cartilage anabolic
genes in both 10-week-old and 62-week-old mice (Table S2). These observations are consistent with
previous data showing up-regulation of these genes in human OA cartilage compared with normal
cartilage [31]. We also found that injured joints of 10-week-old mice had higher expression of these
genes compared with injured joints of 62-week-old mice, suggesting that young mice are more actively
trying to repair the cartilage after injury (Figure 3C). However, immunohistochemical analysis of Chad
showed a significant reduction in protein expression in the injured joints of both 10-week-old and
62-week-old mice at six-week post-injury. This suggests that increased expression of cartilage anabolic
genes after injury was not sufficient to prevent cartilage degeneration.
Cartilage intermediate layer protein 2 (CILP-2) is a protein that is localized in the deeper
intermediate zone of the articular cartilage extracellular matrix and was down-regulated in mouse OA
cartilage [32]. Serum levels of CILP-2 appear to be associated with loss of cartilage thickness in certain
individuals with increased risk of developing knee osteoarthritis [33]. We found that Cilp2 showed
an age-dependent decrease in expression (Table S1). Our data also showed down-regulation of Cilp2
immediately post-injury in both 10-week-old and 62-week-old mice; however, it was up-regulated at
later timepoints in both age groups (Table S2). Several genes involved in matrix degradation including
MMPs (Mmp2, -3, -12, -14, -19), ADAMTS (Adamts4, -6, -12, -15, -16) and HtrA serine peptidase 1
and 3 were also up-regulated in both young and old mice after injury and may play a role in tissue
remodeling after joint injury.
Expression of collagen crosslinking enzymes lysyl oxidases (Lox, Loxl2, and loxl3) also decreased
with age (Figure S3C). Lysyl oxidases play a key role in physiological and pathological remodeling
of extracellular matrix and it has been shown that systemic LOXL2 adenovirus or LOXL2 genetic
overexpression in mice can protect against OA [34]. Procollagen-lysine,2-oxoglutarate 5-dioxygenase
2 (Plod2), another collagen processing enzyme, also had significantly lower expression in old mice
compared with young. Mutations in PLOD2 cause Bruck syndrome (BS), a rare congenital connective
tissue disorder characterized by a combination of joint contractures with various skeletal anomalies [35].
It has been suggested that PLOD2 plays a role in synovial fibrosis, a major contributor to joint stiffness in
OA [36]. scRNA-seq analysis of adult mouse knee joints cartilage indicated that chondrocytes robustly
express this gene (Figure S3B), suggesting that Plod2 plays a role in maintaining cartilage homeostasis.
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We observed a significant up-regulation of transcripts encoding these collagen processing enzymes
after injury in both age groups at various post injury timepoints, possibly as a mechanism to prevent
cartilage damage (Table S2). However, immunohistochemistry analysis of Plod2 showed a decrease in
protein expression in injured joint at six-week post-injury, which was consistent with what we observed
for cartilage matrix protein Chad (Figure 5C,D). We only examined the cartilage for protein expression,
and other cells in the joint such as osteoblasts, fibroblasts, or immune cells may have contributed to
the up-regulation of the transcript levels of these genes, in which case the non-chondrocyte derived
RNA would account for higher transcript levels in the injured joints. Differences in the rates of
RNA and protein metabolism could also have contributed to this inconsistency. Further studies are
required to understand how protein metabolism is regulated after injury and how this plays a role in
cartilage degeneration.
Very few genes were down-regulated in both age groups after injury. Cytokine-like 1 (CYTL1) is a
cytokine that has been shown to promote chondrogenic differentiation of mesenchymal stem cells [14],
and Cytl1 knock-out mice were more sensitive to osteoarthritic (OA) cartilage destruction than wildtype
mice [15]. Cytokine-like 1 (CYTL1) was down-regulated in both young and old mice after injury
(Table S2). Cytl1 also showed a reduced expression in 62-week-old mice compared with 10-week-old
mice. Furthermore, we found that in adult mice Cytl1 expression is restricted to a subset of chondrocytes,
which also express high levels of Bmp2, a key regulator of chondrogenic differentiation [16]; Wnt inhibitor
Wif1; and lubricin (Prg4), a gene involved in boundary lubrication [37] (Figure 6C–E). Wif1 is expressed
at cartilage-mesenchyme interfaces and neutralizes Wnt3a-mediated inhibition of chondrogenesis [17].
It has been shown that Prg4-expressing cells located at the embryonic joint surface serve as a progenitor
population for all deeper layers of the mature articular cartilage [38]. It has also been shown that Prg4
plays an important anti-inflammatory role in regulating synoviocyte proliferation in OA and reduces
basal and IL-1β-stimulated expression of matrix degrading enzymes [18]. Co-localization of Cytl1 with
these genes indicate that Cytl1 plays a role in chondrocyte differentiation and maintenance. Consistent
with our RNA-seq data, immunohistochemical analysis showed that Cytl1 expression is reduced after
injury in both age groups (Figure 6A,B). Our data suggest that age- or injury-induced decrease of Cytl1
could negatively affect cartilage homeostasis and contribute to joint degeneration.
Our study shows clear age-related structural and transcriptional differences in the murine knee
joints after injury. One major limitation of this study is the use of mouse models instead of human
subjects. The murine models may not fully recapitulate the changes seen in the human joints as a result
of age or injury. Several studies have used human biopsy samples to investigate OA pathogenesis,
but there are limitations in terms of the types of studies that can be conducted using human subjects
as it is difficult to obtain biopsy samples from healthy and diseased human knee joints at multiple
timepoints. However, murine models allow us to overcome some of the limitations of human data, by
allowing us to conduct longitudinal studies and gain insights into PTOA development and progression.
Another limitation of our study is that injury-induced transcriptional changes were identified relative
to uninjured contralateral joint, which may have caused us to underestimate injury-induced systemic
changes that may affect both joints. Our previous studies have shown that the expression of several
inflammatory cytokines was up-regulated in both injured and uninjured contralateral joints in response
to injury, although the level of activation in the contralateral was significantly lower than injured
joints. Using contralateral joints as controls may not accurately capture such injury-induced systemic
changes. Also, transcriptome data were obtained from whole joints, which makes it difficult to tease
out the cell type-specific gene expressions changes. To overcome this challenge, we have examined
tissue specific expression of selected proteins using other techniques such as immunohistochemistry
and scRNA-seq. Nevertheless, this study provides novel insights into genes and molecular pathways
involved in the PTOA development in young and old. Our data suggest that increased inflammation
and reduced cartilage anabolism as a result of aging may contribute to a severe PTOA phenotype in old
individuals. Keeping inflammation under control after joint injury may be beneficial in preventing or
at least slowing down cartilage damage. This study also identified several potential therapeutic targets
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for PTOA including collagen metabolism enzymes such as lysyl oxidases and Plod2 and proteins such
as Cytl1. In summary, this study highlights several new genes and molecular pathways that play a
role in PTOA pathogenesis in young and old mice, and the data presented herein could help facilitate
future research, which could aid the development of novel therapeutic approaches for PTOA.
4. Materials and Methods
4.1. Tibial Compression Overload Injury
Right knee joints of 10-week-old and 62-week-old C57BL/6J mice (Jackson Laboratory, Bar Harbor,
ME, USA; Stock No: 000664) received a single non-invasive tibial compression overload at 1 mm/s
displacement rate until ACL rupture using an electromagnetic material testing system (ElectroForce
3200, TA Instruments, New Castle, DE, USA), as previously described [8,10,19]. Buprenorphine
was administered immediately post-injury (0.01 mg/kg) for pain relief. All animal experimental
procedures were completed in accordance with the Institutional Animal Care and Use Committee
(IACUC) guidance at Lawrence Livermore National Laboratory and the University of California, Davis
in AAALAC-accredited facilities under protocol 168 approved in February 2019.
4.2. Histological Assessment of Disease Severity
Injured and uninjured (contralateral) joints were collected at six-week post-injury and processed
as previously described for histology [10]. Briefly, dissected joints were fixed in 4% paraformaldehyde,
decalcified using 0.5 M EDTA, processed, and embedded intact into paraffin. The joints were sectioned
in the sagittal plane and serial medial sections that included the femoral condyles, menisci, and tibial
plateaus were cut at 4 µm; stained on glass slides using 0.1% Safranin-O (0.1%, Sigma, St. Louis,
MO, USA; S8884) and 0.05% Fast Green (0.05%, Sigma, St. Louis, MO, USA; F7252) using standard
procedures (IHC World, Woodstock, MD, USA); and imaged using a Leica DM5000 microscope.
Blinded slides were evaluated by seven scientists (six with and one without expertise in OA) utilizing
modified (sagittal) Osteoarthritis Research Society International (OARSI) scoring parameters because
of the severity of the phenotype six weeks following TC injury. Modified scoring scores (0) for intact
cartilage staining with strong red staining on the femoral condyle and tibia, (1) for minor fibrillation
without cartilage loss, (2) for clefts below the superficial zone, (3) for cartilage thinning on the femoral
condyle and tibia, (4) for lack of staining on the femoral condyle and tibia, (5) for staining present on
90% of the entire femoral condyle with tibial resorption, (6) for staining present on over 80% of the
femoral condyle with tibial resorption, (7) for staining present on 75% of the femoral condyle with
tibial resorption, (8) for staining present on over 50% of the femora condyle with tibial resorption, (9),
for staining present in 25% of the femoral condyle with tibial resorption, and (10) for staining present
in less than 10% of the femoral condyle with tibial resorption.
4.3. Micro-Computed Tomography (µCT)
Whole knee joints from both young and old mice (n ≥ 5 per group) were scanned using µCT
(SCANCO µCT 35, Brüttisellen, Switzerland) at six-week post injury as previously described [10],
according to the rodent bone structure analysis guidelines (X-ray tube potential = 55 kVp, intensity
= 114 µA, 10 µm isotropic nominal voxel size, integration time = 900 ms). Trabecular bone in the
distal femoral epiphysis was analyzed by manually drawing contours on 2D transverse slides. The
distal femoral epiphysis was designated as the region of trabecular bone enclosed by the growth plate
and subchondral cortical bone plate. Epiphyseal trabecular bone volume fraction was determined
by quantifying trabecular bone volume per total volume (BV/TV). Mineralized osteophyte volume in
injured and contralateral joints was quantified by drawing contours around all heterotropic mineralized
tissue attached to the distal femur and proximal tibia as well as the whole fabellae, menisci, and patella.
Total mineralized osteophyte volume was then determined as the volumetric difference in mineralized
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tissue between injured and uninjured joints. Statistical analysis was performed using a paired t-test to
compare injured and contralateral knees.
4.4. Immunohistochemistry (IHC)
Sagittal six-micrometer sections from injured and uninjured samples from both age groups of
C57Bl/6J mice were used for IHC. Unitrieve was used as an antigen retrieval method for 30 min at 65 ◦C.
Primary antibodies: CYTL1 (Proteintech, Rosemont, IL, USA; 15856-1-AP(1:75)), PLOD2 (Invitrogen,
Carlsbad, CA, USA; PA5-69194(1:100)), and CHAD (Invitrogen, Carlsbad, CA, USA; PA5-53761(1:300))
were used and incubated overnight at room temperature in a dark, humid chamber. Negative control
slides were incubated with secondary antibody-only. Stained slides were mounted with Prolong
Gold with DAPI (Molecular Probes, Eugene, OR, USA). Slides were imaged using a Leica DM5000
microscope. ImagePro Plus V7.0 Software and a QIClick CCD camera (QImaging, Surrey, BC, Canada)
were used for imaging and photo editing.
4.5. Bulk RNA Sequencing and Data Analysis
The knee joint RNA from 10-week-old, 62-week-old, and 95-week-old mice was isolated as
described before [10]. Briefly, injured and contralateral joints (n = 3–6 per group) were dissected,
chopped, and homogenized in Qiazol (79306, Qiagen, Valencia, CA, USA). Total RNA was purified
using RNeasy Mini Kit (QIAGEN Inc., Germantown, MD, USA) according to the manufacturer’s
protocol and the RNA integrity was assessed using a bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA). Poly(A)+-enriched cDNA libraries were generated using the Illumina TruSeq
RNA Library Prep kit v2 (Illumina Inc., Hayward, CA, USA). The sequencing was performed
using an Illumina (Illumina Inc., Hayward, CA, USA) NextSeq 500 instrument to generate 75 bp
single-end reads. The quality of sequencing data was checked using FastQC (version 0.11.5) software
[http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc]. Sequence reads were mapped to the mouse
reference genome (mm10) using STAR (version 2.6) [39]. A matrix of raw counts per gene was
generated using “featureCounts” from Rsubread package (version 1.30.5) [40]. RUVseq was used to
determine factors of unwanted variation [41]. Differentially expressed genes were identified using
edgeR, adjusting for factors of unwanted variation [42]. Genes with fold changes >1.5 and false
discovery rate (FDR) adjusted p-value less than 0.05 were considered as significantly differentially
expressed. Heatmaps were generated using heatmap.2 function in R package ‘gplots’.
4.6. Single Cell RNA-Seq (scRN-Aseq) and Data Analysis
Ten-week-old C57Bl/6J mice were euthanized, and right and left hindlimbs were collected by
removing the leg at the hip joint and storing on ice in Dulbecco’s Modified Eagle Medium Nutrient
Mixture F-12 (DMEM/F-12) (Thermo Fisher Scientific, Waltham, MA, USA). The articular cartilage of
the knee joint was isolated from the femur and tibia by cutting 0.5–1 mm of tissue from the end of both
long bones. Cartilage tissue was digested to a single cell suspension in 1 mL of 0.2% Collagenase 2
solution (Thermo Fisher Scientific, Waltham, MA, USA) while shaking at 37 ◦C for 2 h. Fractions were
collected at 30 min intervals, filtered through a 70 µm Nylon cell strainer, and then resuspended in
DMEM/F12 with 10% fetal bovine serum (FBS). Remaining undigested cartilage tissue was further
incubated in 1 mL of fresh Collagenase 2 digestion media.
Following digestion, cell suspensions were pelleted via centrifugation for 10 min at 500 G, then
resuspended in ACK lysis buffer (Thermo Fisher Scientific, Waltham, MA, USA), and incubated
for 10 min on ice in order to remove red blood cells. Cell suspensions were next resuspended in
100 uL of PBS + 10% FBS. CD45+ and Ter119+ cell depletion was accomplished using CD45 and
Ter119 MACSmicrobeads (Miltenti Biotec, Sunnyvale, CA, USA) and running cell samples on an
LS MACScolumns (Miltenti Biotec, Sunnyvale, CA, USA) following the manufacturer’s instructions.
Final cell counts were performed using a hemocytometer and cells were resuspended in PBS + 0.04%
nonacetylated BSA before introduction into a Chromium Controller (10x Genomics, Pleasanton, CA,
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USA). Library preparation was performed using Chromium Single Cell 3′ GEM, Library & Gel Bead Kit
v3 (10x Genomics, Pleasanton, CA, USA; Catalog no. 1000075) following the manufacturer’s protocol
and sequenced using Illumina NextSeq 500. Sequencing data were demultiplexed, quality controlled,
and aligned to the mouse genome (mm10) using Cell Ranger (10x Genomics, Pleasanton, CA, USA).
Data analysis was performed using Seurat (version 3.1.1) [43].
4.7. Functional Annotation
Gene ontology analysis was performed using ToppGene and ToppCluster [44] and enriched gene
ontology terms and pathways (p-value < 0.01) were identified. Cytoscape (version 3.6.1) was used for
ontology and pathway visualization [45].
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/1/364/s1.
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